<DOC>
	<DOC>NCT01145222</DOC>
	<brief_summary>The purpose of this dose-response study is to assess the safety and efficacy of CNS 7056 compared with midazolam to maintain suitable sedation levels in patients undergoing colonoscopy.</brief_summary>
	<brief_title>Multiple Dose Safety and Efficacy Study Evaluating CNS 7056 Versus Midazolam in Patients Undergoing Colonoscopy</brief_title>
	<detailed_description>This is a double-blind, randomized, parallel group, dose-response study to assess the safety and efficacy of three dose levels of CNS 7056 compared with midazolam to maintain suitable sedation levels in patients undergoing colonoscopy. Safety assessment will include physical examinations, vital signs, ECGs, pulse oximetry measurements, capnography, clinical chemistry and hematology laboratory tests, routine drug and ethanol screening, urinalysis, pregnancy test, pain on injection using a verbal scale, and monitoring of adverse events.</detailed_description>
	<mesh_term>Midazolam</mesh_term>
	<criteria>Male and female patients 18 to 70 years of age scheduled to undergo a standard colonoscopy American Society of Anesthesiologists Physical Status (ASAPS) Score I, II, or III Weight range 55 to 130 kg inclusive BMI 18 ≤33 kg/m2 Expected duration of colonoscopy &gt;30 minutes Patients with a suspected or diagnosed pathology of the lower GI tract that would add to the risk of colonoscopy, such as strictures or active inflammatory bowel disease ASA III patients with history of sleep apnea ASA III patients with obesity (BMI ≥30 kg/m2) Patients with evidence of uncontrolled renal, hepatic, central nervous system, respiratory, cardiovascular or metabolic dysfunction, or other clinically significant findings at screening that, in the investigator's or medical monitor's opinion, should exclude them from the study Patients with a known sensitivity to benzodiazepines, flumazenil, opioids, naloxone, or a medical condition such that these agents are contraindicated Patients in whom management of airway is judged to be difficult due to thyromental distance ≤4 cm ("short neck") or Mallampati score of 4</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>CNS 7056</keyword>
	<keyword>Procedural Sedation</keyword>
	<keyword>Colonoscopy</keyword>
</DOC>